pU6-Osp.gRNA-MS2in Citations (1)

Originally described in: Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy.
Ling S, Zhang X, Dai Y, Jiang Z, Zhou X, Lu S, Qian X, Liu J, Selfjord N, Satir TM, Lundin A, Touza JL, Firth M, Van Zuydam N, Bilican B, Akcakaya P, Hong J, Cai Y Nat Nanotechnol. 2025 Apr;20(4):543-553. doi: 10.1038/s41565-024-01851-7. Epub 2025 Feb 10. PubMed Journal

---

Articles Citing pU6-Osp.gRNA-MS2in

Articles
Genome-wide screening reveals producer-cell modifications that improve virus-like particle production and delivery potency. Ly D, Jang H, Goel A, Singh A, Raguram A. Nat Commun. 2026 Apr 24;17(1):3695. doi: 10.1038/s41467-026-71925-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.